Edge Wealth Management LLC Increases Stock Position in Oracle Co. (NYSE:ORCL)

by · The Cerbat Gem

Edge Wealth Management LLC increased its position in Oracle Co. (NYSE:ORCLFree Report) by 38.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,790 shares of the enterprise software provider’s stock after purchasing an additional 500 shares during the quarter. Edge Wealth Management LLC’s holdings in Oracle were worth $250,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank bought a new position in Oracle during the 4th quarter valued at $2,216,314,000. Raymond James Financial Inc. bought a new position in Oracle during the 4th quarter valued at $930,095,000. GAMMA Investing LLC raised its holdings in shares of Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider’s stock worth $664,810,000 after purchasing an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Oracle by 20.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider’s stock worth $2,303,858,000 after purchasing an additional 2,350,448 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of Oracle by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider’s stock worth $26,231,127,000 after purchasing an additional 2,296,069 shares during the period. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Leon E. Panetta sold 5,000 shares of the firm’s stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the transaction, the director now owns 58,090 shares in the company, valued at approximately $7,538,339.30. This trade represents a 7.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Naomi O. Seligman sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total transaction of $291,620.00. Following the transaction, the director now owns 34,630 shares of the company’s stock, valued at approximately $5,049,400.30. This trade represents a 5.46% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,366 shares of company stock worth $4,015,723. Corporate insiders own 42.20% of the company’s stock.

Wall Street Analysts Forecast Growth

ORCL has been the topic of a number of research reports. Monness Crespi & Hardt raised shares of Oracle from a “sell” rating to a “neutral” rating in a report on Monday, March 3rd. DA Davidson dropped their target price on shares of Oracle from $150.00 to $140.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Barclays dropped their target price on shares of Oracle from $212.00 to $202.00 and set an “overweight” rating on the stock in a report on Tuesday, March 11th. Stephens initiated coverage on shares of Oracle in a report on Wednesday, March 19th. They set an “equal weight” rating and a $167.00 target price on the stock. Finally, Morgan Stanley dropped their target price on shares of Oracle from $170.00 to $160.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 16th. Fourteen equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Oracle has an average rating of “Moderate Buy” and a consensus target price of $174.42.

Check Out Our Latest Analysis on Oracle

Oracle Stock Up 1.8%

Oracle stock opened at $171.16 on Friday. The stock has a market cap of $478.73 billion, a price-to-earnings ratio of 41.85, a PEG ratio of 3.46 and a beta of 1.32. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The company’s 50-day moving average price is $146.56 and its two-hundred day moving average price is $160.77. Oracle Co. has a 52 week low of $118.86 and a 52 week high of $198.31.

Oracle (NYSE:ORCLGet Free Report) last released its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.02). The company had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.41 EPS. On average, analysts expect that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Thursday, April 10th were given a dividend of $0.50 per share. This is a positive change from Oracle’s previous quarterly dividend of $0.40. The ex-dividend date was Thursday, April 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.17%. Oracle’s dividend payout ratio (DPR) is 46.95%.

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).